Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;84:1113-1115

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kita, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kita, T.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Pathophysiology
Right arrow Lipid and lipoprotein metabolism
(Circulation Research. 1999;84:1113-1115.)
© 1999 American Heart Association, Inc.


Editorials

LOX-1, a Possible Clue to the Missing Link Between Hypertension and Atherogenesis

Toru Kita, MD

From the Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.

Correspondence to Toru Kita, MD, Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan. E-mail tkita@kuhp.kyoto-u.ac.jp


Key Words: angiotensin II • oxidized LDL • LOX-1 • endothelial cell • atherosclerosis

Our understanding of the molecular mechanism of atherosclerosis has changed during the past 20 years. A large variety of different risk factors such as smoking, shear stress, hypertension, hypercholesterolemia, diabetes mellitus, and obesity lead to endothelial activation and/or dysfunction, which can elicit a series of cellular interactions that culminate in the lesions of atherosclerosis. To date, there have been many studies investigating how hypercholesterolemia, particularly hyperLDL-cholesterolemia, affects endothelial cells and forms atherosclerotic lesions.1 2 3 Although hypertension is an established risk factor for the development of atherosclerosis, the underlying molecular mechanisms have not been clearly elucidated. There is a great deal of experimental, epidemiological, and clinical evidence suggesting that the renin-angiotensin system plays an important role in the pathogenesis of atherosclerotic formation. It has been suggested that hypertensive patients with high renin profiles, who are likely to be associated with increased plasma angiotensin II (Ang II) levels, have a higher risk of myocardial infarction than those with low renin profiles.4 5 Several experimental studies on hyperlipidemic animal models have suggested that interaction of the renin-angiotensin system and hyperLDL-cholesterolemia could play an important role in atherogenesis. In addition, it has been shown that angiotensin-converting enzyme (ACE) inhibitors reduce atherosclerotic formation in several experimental animal models, such as Watanabe heritable hyperlipidemic (WHHL) rabbits, cholesterol-fed mice, and monkeys.6 7 8 9

The study in this issue of Circulation Research presented by Li et al10 demonstrated that Ang II increases uptake of oxidized LDL (ox-LDL) by human coronary artery endothelial cells (HCAECs) via an induced LOX-1 expression and enhanced ox-LDL–mediated . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Nutr.Home page
Y.-P. Lei, H.-W. Chen, L.-Y. Sheen, and C.-K. Lii
Diallyl Disulfide and Diallyl Trisulfide Suppress Oxidized LDL-Induced Vascular Cell Adhesion Molecule and E-Selectin Expression through Protein Kinase A- and B-Dependent Signaling Pathways
J. Nutr., June 1, 2008; 138(6): 996 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Morawietz
LOX-1 and Atherosclerosis: Proof of Concept in LOX-1-Knockout Mice
Circ. Res., June 8, 2007; 100(11): 1534 - 1536.
[Full Text] [PDF]


Home page
J BiochemHome page
T. Ishigaki, I. Ohki, N. Utsunomiya-Tate, and S.-i. Tate
Chimeric Structural Stabilities in the Coiled-Coil Structure of the NECK Domain in Human Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 (LOX-1)
J. Biochem., June 1, 2007; 141(6): 855 - 866.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Elitok, S. V. Brodsky, D. Patschan, T. Orlova, K. M. Lerea, P. Chander, and M. S. Goligorsky
Cyclic arginine-glycine-aspartic acid peptide inhibits macrophage infiltration of the kidney and carotid artery lesions in apo-E-deficient mice
Am J Physiol Renal Physiol, January 1, 2006; 290(1): F159 - F166.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Chen, J. Chen, Y. Liu, J. Xie, D. Li, T. Sawamura, P. L. Hermonat, and J. L. Mehta
Adhesion Molecule Expression in Fibroblasts: Alteration in Fibroblast Biology After Transfection With LOX-1 Plasmids
Hypertension, September 1, 2005; 46(3): 622 - 627.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Kume and T. Kita
Apoptosis of Vascular Cells by Oxidized LDL: Involvement of Caspases and LOX-1 and Its Implication in Atherosclerotic Plaque Rupture
Circ. Res., February 20, 2004; 94(3): 269 - 270.
[Full Text] [PDF]


Home page
HypertensionHome page
B. Halvorsen, A. C. Staff, T. Henriksen, T. Sawamura, and T. Ranheim
8-iso-Prostaglandin F2{{alpha}} Increases Expression of LOX-1 in JAR Cells
Hypertension, April 1, 2001; 37(4): 1184 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Chen, M. Kakutani, M. Minami, H. Kataoka, N. Kume, S. Narumiya, T. Kita, T. Masaki, and T. Sawamura
Increased Expression of Lectinlike Oxidized Low Density Lipoprotein Receptor-1 in Initial Atherosclerotic Lesions of Watanabe Heritable Hyperlipidemic Rabbits
Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1107 - 1115.
[Abstract] [Full Text] [PDF]